S
Siemens Healthineers
Designs, develops, and manufactures diagnostic imaging systems, clinical solutions, and minimally invasive procedural equipment for healthcare providers worldwide
About Siemens Healthineers
Siemens Healthineers traces its roots back to 1847 when Werner von Siemens and Johann Georg Halske founded the company Telegraphen-Bauanstalt von Siemens & Halske in Berlin. This marked the beginning of a legacy in engineering and innovation that would eventually lead to the creation of Siemens Healthineers, a leader in the healthcare technology sector.
In March 2018, Siemens Healthineers made a significant leap by going public. The IPO was a major event, raising approximately $4.2 billion and marking one of the largest healthcare IPOs globally. This move allowed Siemens Healthineers to gain greater financial independence and flexibility, enabling further investment in research and development.
Today, Siemens Healthineers stands as a testament to over 170 years of innovation, continuously evolving to meet the demands of modern healthcare. The company focuses on providing cutting-edge medical technologies and services, aiming to improve patient care and streamline clinical operations worldwide. From its early beginnings in telegraphy to its current status as a healthcare giant, Siemens Healthineers exemplifies a commitment to advancing human health through technology.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1847
- Headquarters
- Forchheim, Germany
- Listing
- IPO 2018
- Employees
- 54,363
- Open positions
- None listed
- Dealroom signal
- 82.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Horizon Europe
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 16 companies, latest Apr 2026
- Capital deployed
- $112M
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Aug 2026 | $31M | — | Advanced Research Projects Agency for Health - ARPA-H | ↗ |
| SECONDARY✓Other financing | Nov 2025 | $0 | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Siemens Healthineers is 7.9M monthly website visits, up 23.4% over the last three months. Siemens Healthineers's team grew 31.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Screenpoint MedicalNijmegen, NetherlandsSmart AI for early breast cancer detection
$140Mvaluation
VedaBioSan Diego, United StatesCRISPR-based molecular detection without target amplification
$200Mvaluation
KromekSedgefield, United KingdomCZT-based radiation and biological threat detection solutions.
$63Mvaluation
Advanced Accelerator ApplicationsSaint-Genis-Pouilly, FranceDevelops diagnostic and therapeutic products in the field of molecular nuclear medicine
$3.9Bvaluation
Block ImagingUnited StatesMedical device company providing imaging equipment and spare parts
→
Babson DiagnosticsAustin, United StatesMedical technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter
$124Mvaluation
Varian Medical SystemsPalo Alto, United StatesA Siemens healthineers company, with a vision of the world without fear of cancer
$16Bvaluation
CorindusNatick, United StatesCorindus develops and commercializes remote robotic systems for interventional procedures
$1.1Bvaluation
Fast Track DiagnosticsEsch-sur-Alzette, LuxembourgGlobal supplier of diagnostics tests
→
MedicalisToronto, CanadaMedicalis Corporation - Welcome to Medicalis
$10Mvaluation
Conworx TechnologyBerlin, GermanyDeveloper of point-of-care device interfaces and data management solutions
→
NEO New OncologyCologne, GermanySpecializing in molecular profiling assays for cancer diagnostics, developing tests to identify genetic changes in tumors and guide targeted therapies
$23Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
HHS Administration for Strategic Preparedness and Response
Advanced Research Projects Agency for Health - ARPA-H
Series B and later1 investor entered at this stage
Siemens
Other known investors2 additional known investors
EPFL Innovation Park
US Biomedical Advanced Research and Development Authority
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Siemens Healthineers on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Siemens Healthineers’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.